Linalool Mitigated High-Fat Diet–Induced Non-alcoholic Fatty Liver Disease by Regulating the Intestinal-Hepatic Axis via TGF-β/NF-kB/TLR4/ZO-1 Pathway DOI

Tamilmani Periyasamy,

V. V. Sathibabu Uddandrao,

P. Chandrasekaran

et al.

Revista Brasileira de Farmacognosia, Journal Year: 2023, Volume and Issue: 33(3), P. 617 - 628

Published: April 11, 2023

Language: Английский

Lipid Disorders and Metabolic-Associated Fatty Liver Disease DOI

Shima Dowla Anwar,

Christy Foster, Ambika P. Ashraf

et al.

Endocrinology and Metabolism Clinics of North America, Journal Year: 2023, Volume and Issue: 52(3), P. 445 - 457

Published: Feb. 26, 2023

Language: Английский

Citations

24

Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise DOI Creative Commons
Thomai Mouskeftara, Olga Deda, Grigorios Papadopoulos

et al.

Molecules, Journal Year: 2024, Volume and Issue: 29(7), P. 1494 - 1494

Published: March 27, 2024

Detailed investigation of the lipidome remodeling upon normal weight conditions, obesity, or loss, as well influence physical activity, can help to understand mechanisms underlying dyslipidemia in metabolic conditions correlated emergence and progression non-alcoholic fatty liver disease (NAFLD). C57BL/6 male mice were fed a diet (ND) high-fat (HFD) for 20 weeks. Subgroups within group underwent different interventions: some engaged exercise (HFDex), others subjected loss (WL) by changing from HFD ND, combination (WLex) during final 8 weeks 20-week feeding period. To support our understanding, not only tissue-specific lipid but also cross-talk between tissues their impact on systemic regulation metabolism are essential. Exercise loss-induced specific adaptations visceral adipose tissue lipidomes explored UPLC–TOF–MS/MS untargeted lipidomics methodology. Lipidomic signatures ND HFD-fed undergoing compared with animals without exercise. Several classes identified contributing factors discrimination groups multivariate analysis models, such glycerolipids, glycerophospholipids, sphingolipids, acids, respect samples, whereas triglycerides class tissue. Lipids found be dysregulated related well-established pathways involved biosynthesis PC, PE, TG metabolism. These show reversing trend back basic levels when change after 12 weeks, exercise, though cases it slightly enhances trend, is clear.

Language: Английский

Citations

10

Metabolic dysfunction-associated steatotic liver disease and atherosclerosis DOI
Yulino Castillo-Núñez, Paloma Almeda‐Valdés, Guillermo González-Gálvez

et al.

Current Diabetes Reports, Journal Year: 2024, Volume and Issue: 24(7), P. 158 - 166

Published: May 3, 2024

Language: Английский

Citations

9

Association between non-alcoholic fatty liver disease and progression of abdominal aortic aneurysm: a multicenter study DOI Creative Commons

Ximing Wang,

Jingxiang Sun, Na Chang

et al.

BMC Medical Imaging, Journal Year: 2025, Volume and Issue: 25(1)

Published: Jan. 20, 2025

The purpose of our study was to investigate the association between non-alcoholic fatty liver disease (NAFLD) and abdominal aortic aneurysms (AAA) progression using non-enhanced computed tomography (CT) CT angiography (CTA). Patients with AAA age- sex-matched healthy subjects who underwent CTA examination January 2015 2023 from four hospitals were retrospectively analyzed. divided into (growth rate > 10 mL/year) non-progression groups, as well those NAFLD without NAFLD, based on results. Kaplan-Meier Cox regression used progression. A total 151 patients (mean age: 69.1 ± 10.5 years old, 133 men) included, among which 66 (43.7%) had NAFLD. During a median 10.7 months (6.0–76.0 months), 57 (37.7%) prevalence significantly higher in group compared control (43.7% vs. 31.1%, p = 0.024). Multivariable analysis revealed that independently associated (HR, 4.28; 95% CI, 2.20–8.31; < 0.001). area under curve combined maximal diameter 0.857 for predicting is an independent predictor It can improve diagnostic efficacy aneurysms. Not applicable. This research retrospective analysis.

Language: Английский

Citations

1

Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum DOI
Juhyeong Hong, Yong‐Hee Kim

Journal of Controlled Release, Journal Year: 2025, Volume and Issue: 380, P. 433 - 456

Published: Feb. 11, 2025

Language: Английский

Citations

1

Normal caloric intake with high-fat diet induces metabolic dysfunction-associated steatotic liver disease and dyslipidemia without obesity in rats DOI Creative Commons
Mateusz Szudzik,

Tomasz Hutsch,

Dawid Chabowski

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: Oct. 1, 2024

Language: Английский

Citations

6

Protective Effects of Hydroxyphenyl Propionic Acids on Lipid Metabolism and Gut Microbiota in Mice Fed a High-Fat Diet DOI Open Access
Jingling Guo, Pan Wang,

Yifan Cui

et al.

Nutrients, Journal Year: 2023, Volume and Issue: 15(4), P. 1043 - 1043

Published: Feb. 20, 2023

Gut microbiota imbalances lead to the pathogenesis of non-alcoholic fatty liver disease (NAFLD), which is primarily accompanied by hepatic steatosis. Hydroxyphenyl propionic acids (HPP) have shown great potential in inhibiting lipid accumulation but their protective effects concerning NAFLD and intestinal remained unclear. In this paper, we investigated efficacies 3-HPP 4-HPP on steatosis gut flora mice fed a high-fat diet (HFD). We found that administration decreased body weight index, ameliorated dyslipidemia, alleviated Furthermore, enhanced multiformity microbiota; improved relative abundance GCA-900066575, unidentified_Lachnospiraceae, Lachnospiraceae_UCG-006 at genus level; increased concentration acetic acid, acid butanoic faeces; reduced systemic endotoxin levels mice. Moreover, upregulated genera Rikenella downregulated Faecalibaculum. regulated metabolism dysbiosis was more effective than 3-HPP.

Language: Английский

Citations

16

A Review of the Effects of Fucoxanthin on NAFLD DOI Open Access
Nor Hafiza Sayuti, Khairul Najmi Muhammad Nawawi, Jo Aan Goon

et al.

Nutrients, Journal Year: 2023, Volume and Issue: 15(8), P. 1954 - 1954

Published: April 19, 2023

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic disease. Fucoxanthin, a red-orange marine carotenoid, found in natural seaweeds with high antioxidant activity and several other remarkable biological features. The aim this review to gather evidence positive benefits fucoxanthin on NAFLD. Fucoxanthin provides an extensive list physiological properties, such as hepatoprotective, anti-obesity, anti-tumor, anti-diabetes addition anti-inflammatory properties. This focuses published research preventative effects NAFLD from perspective human clinical trials, animal experiments vivo, vitro cell investigations. Using variety experimental designs, including treatment dosage, experiment model, periods, were demonstrated. Fucoxanthin’s activities outlined, emphasis its therapeutic efficacy showed beneficial modulating lipid metabolism, lipogenesis, acid oxidation, adipogenesis, oxidative stress A deeper comprehension pathogenesis essential for development novel effective strategies.

Language: Английский

Citations

11

Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation DOI
Navya Malladi,

Devidas Lahamge,

Balaji Sanjay Somwanshi

et al.

Cellular Signalling, Journal Year: 2024, Volume and Issue: 121, P. 111299 - 111299

Published: July 14, 2024

Language: Английский

Citations

4

Statins and non-alcoholic fatty liver disease: A concise review DOI Open Access
Evelyn Nunes Goulart da Silva Pereira, Ricardo Franco, Raul D. Santos

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2025, Volume and Issue: 183, P. 117805 - 117805

Published: Jan. 5, 2025

Language: Английский

Citations

0